Filter
515
Filtered Results: 515
Text search:
BioNTech
Featured
Recommendations
61
New Publications
77
Language
Document type
No document type
160
Studies & Reports
119
Guidelines
104
Fact sheets
52
Manuals
37
Strategic & Response Plan
15
Training Material
7
Situation Updates
6
Infographics
6
Resource Platforms
4
Online Courses
3
Brochures
1
Videos
1
Countries / Regions
India
42
Global
22
Germany
19
Brazil
13
South Africa
11
Russia
11
Nepal
10
Ukraine
10
Latin America and the Carribbean
9
Argentina
9
Mozambique
8
Africa
7
Middle East and North Africa
7
Rwanda
5
Bangladesh
5
Nigeria
4
West and Central Africa
4
Western and Central Europe
4
Paraguay
4
Zambia
4
Colombia
3
Kenya
3
China
3
Chile
3
Cameroon
3
South–East Asia Region
3
East and Southern Africa
3
Uganda
3
Ethiopia
3
Ecuador
3
Myanmar / Burma
3
Thailand
2
Syria
2
Senegal
2
Peru
2
Malawi
2
Zimbabwe
2
Philippines
2
USA
2
Asia
2
Tanzania
2
Spain
2
Vietnam
2
Namibia
2
Angola
2
Botswana
2
El Salvador
1
Turkey
1
Ghana
1
Benin
1
Sierra Leone
1
Kazakhstan
1
Iran
1
Afghanistan
1
Guinea
1
Haiti
1
Cambodia
1
Guinea-Bissau
1
Congo, Democratic Republic of
1
Eastern Europe and Central Asia
1
France
1
United Kingdom
1
Portugal
1
Belarus
1
Southern Africa
1
Papua New Guinea
1
Sudan
1
Yemen
1
Central African Republic
1
Libya
1
South Sudan
1
Iraq
1
Somalia
1
Liberia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
COVID-19
90
Guidelines
58
Studies & Reports
37
Drugs & Medical Equipment
21
Policies
20
Information, Education and Communication (IEC)
12
Policies & Guidelines HIV & TB
11
Virology
8
Capacity Building
8
Women & Child Health
6
Parasitology
6
x MEDBOX Issue Brief & Annual Reports x
5
Infection Control & Prevention (IPC)
5
Demograhic Health Surveys DHS
5
Disaster Preparedness
4
Vaccine-preventable Diseases
4
Community Health
4
Waste Management
4
HIV & STI
4
Malaria
4
Disease Prevention & Control
4
General Guidelines
3
MPOX - Monkeypox
3
Statistics
3
TB
3
Food Security & Nutrition
3
Paediatrics
2
Pharmacy & Technology
2
Diabetes
2
Schistosomiasis
2
Pediatrics
2
Diarrhoeal Disease/Cholera
2
Yellow Fever
2
Humanitarian Crisis
2
General Guidelines
2
Dengue
2
Hepatitis
1
Family Planning
1
Under-5 nutrition
1
Child Health
1
Bacteriology
1
Laboratory Waste
1
Annual Report MEDBOX
1
Monitoring & Evaluation
1
Community Health
1
Countries
1
Health System Strengthening
1
Chagas
1
Hemorrhagic Fever
1
Medical Devices & Equipment
1
Diarrhoea
1
Immunization
1
Quality Control & Assurance
1
Leprosy
1
Leishmaniasis
1
Laboratory Technologies
1
Laboratory Quality Assurance
1
Age & Elderly
1
Pharmacy & Technologies
1
Radiology and Diagnostic
1
Toolboxes
Country specific documents
48
Biontech/Pfizer Comirnaty
23
Communication Material
19
COVID-19 Vaccination Information
19
Access & Strategy
15
Immunization Guidelines
15
COVID-19 Vaccination
13
Logistics & Supply
13
Diagnostics & Laboratory Guidance
10
Fair Allocation & Ethical Aspects
10
Country specific
9
Clinical Guidelines
9
Studies
9
Laboratory Guidance
8
Hospital Readiness/Essential Health Services
8
Genomic sequencing
8
Vaxzevria (Astra Zeneca)
8
Booster Doses
8
Vaccine Hesitancy & Myths
7
Moderna
7
Waste Managment
7
Prevention & Preparedness
6
Global Impact: Socio-economic, health services, TB & HIV
6
Covaxin
6
HIV testing & services
5
Infection Control General
5
For General Public & Community
5
Training, others
5
For Migrants & Refugees
5
mRna Vaccines general
5
Vector-based Vacines General
5
Inactivated COVID-19 Vaccines
5
General documents One Health
5
Information Refugees Ukraine
5
COVID-19
5
Education material
5
Research & Access
5
Testing Guidelines
5
Outbreak Prevention & Control
4
Public Health
4
Research
4
Laboratory
4
Physical Distancing
4
Encyclical Letters
4
Dashboards & Resource Platforms
4
Health Financing Toolbox
4
Vaccines & Immunization
3
Influenza Prevention & Control
3
Anamnesis / Screening
3
Preparedness, Response & Risk Communication
3
Online Courses & Resources
3
For Health Worker
3
Country Specific
3
For Older People
3
Educational Settings
3
Workplace
3
Videos
3
Vaccine Candidates & Research
3
Non-pharmaceutical interventions (NPIs)
3
SARS-CoV-2 Variants
3
Long COVID/ Post-COVID Syndrome
3
Research & Pipeline
3
Waste Management
3
Biodiversity shift
3
Essential Medicines
3
MPOX - Monkeypox
3
MPOX - Monkeypox
3
General Information & Methodology
3
Assessment & Studies
2
Biosafety
2
Surveillance
2
Agriculture & Veterinary
2
Clinical Aspects, Treatment & Prevention
2
Yellow Fever Prevention & Control
2
Preparedness, Response & Risk Communication
2
Vaccination
2
Social Worker
2
International
2
Climate & Health
2
General
2
Context & Facts, Travel Advice
2
For Parents & Children
2
For Pregnant Women
2
Human Rights
2
Social Ethics
2
Paediatrics
2
Oxygen Therapy
2
Essential Medicines & Medical Devices
2
Vaccination & Strategy
2
Long-term Care Facilities
2
Ethics
2
Climate Change General
2
Agriculture
2
Rational use of Medicine
2
Traditional & Herbal Medicines
2
Land-system change
2
Situation Reports & Updates
2
Guidelines & Manuals
2
Zoonoses
2
Infectious Diseases
2
Others
2
Water Pollution
2
Health Impact & Climate Change
2
General
2
Clinical Aspects & Diagnostics
2
Studies & Reports
2
Studies & Reports
2
Studies & Reports
2
Studies & Reports
2
Overview, Studies & Reports
2
Detection & Diagnosis
2
Clinical Guidelines
2
General
2
Nutrition
2
Germany
2
Vision Loss & Blindness
2
Assessment
2
TB
2
Refugees & Migrants
2
Volunteers
2
Drugs
1
Treatment Guidelines
1
ART Drug Resistance
1
Local Action
1
General Reports
1
TB & Drug Abuse
1
Clinical Guidelines
1
IPC
1
Training
1
Surveillance
1
Chemical Attacks
1
Treatment & Prevention
1
Yellow Fever
1
Prevention & Control
1
Key Resources
1
Adults
1
Pediatrics
1
Information for Refugees & Migrants
1
Introduction to Global Health
1
WASH
1
Influenza
1
Infection Control
1
Public Health
1
Treatment Guidelines HIV
1
Laboratory
1
Sexually Transmitted Infections
1
Cholera Prevention & Control
1
Rwanda
1
Health Equity & Equality
1
Clinical aspects
1
Child Health / Pediatrics
1
Women's Mental Health
1
Laboratory & Sampling
1
PPE Personel Protective Equipment
1
Sustainable Development Goals
1
General
1
Treatment Guidelines
1
Situation Reports & Updates
1
Research & Development
1
Livestock production
1
COVID-19
1
Clinical Aspects
1
Public Health
1
PPE Personel Protective Equipment
1
Poster & Infographics
1
Surveillance & Contact tracing
1
COVID-19 Information
1
For People with Disabilities
1
Appeals and Response Plans
1
Dashboards & Maps
1
Scientific & Research Studies
1
Resource Platforms others
1
Catholic Social Teaching (CST)
1
Health Care Professionals & Spirituality
1
Blood Supply
1
TB/HIV
1
Presentation
1
Preparedness, Response & Risk Communication
1
COVAX Initiative
1
Johnson & Johnson
1
Sputnik V
1
Standard Operating Procedure (SOP)
1
Chile
1
Planetary Health
1
Food environments
1
Overview & reports
1
Clean air
1
Essential Medicines & Devices Lists
1
Prices and Patents
1
Falsified & Substandard
1
Model Formulary
1
Pharmacy Management
1
Quality Assurance
1
Standard Operating Procedures (SOPs)
1
Strategies
1
Guiding documents and principles
1
Climate Change
1
Pharmacovigilance
1
Reports & Studies
1
General
1
Nuclear & Chemical Hazards
1
Chagas
1
Leishmaniasis
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Statistics & Facts
1
Studies & Reports
1
Studies & Reports
1
Studies & Reports
1
Access to treatment and laboratory
1
General Information
1
Prevention & Strategies
1
Studies & Reports
1
Capacity Building & Resources
1
Risk Factors
1
Women
1
Global Overview
1
General
1
Diagnosis
1
Drug resistant TB
1
Neurological Disorders
1
Alzheimer's Disease & Dementia
1
Bipolar Affective Disorders
1
Human Rights & the Right to Health
1
TB & Prisoners
1
Education of students & professionals
1
Training
1
Dengue Prevention & Control
1
General Public
1
HIV and coinfection
1
Others
1
Global Health Institutions and Stakeholders
1
Antiretroviral Treatment ART
1
Infection Control
1
Context & Facts
1
Laboratory & Diagnostics
1
Global Health Action
1
AMR
1
Reports & Studies
1
Capacity Building
1
Neurological disorders, Others
1
Global Health Ethics
1
SEAR (South-east Asia Region)
1
Eastern Europe and central Asia
1
Treatment & Clinical Management
1
These guidelines have been developed for scientific purpose with the main aim to guide the regulatory authority for evaluating probiotic products in our country.
The guidelines reiterate that the general principles of ethics for biomedical research involving human participants shall also be applicable. In addition, the guidelines specify unique provisions for stem cells, because of their inherent property for unlimited proliferation, differentiation to cells...
Original Research
African Journal of Primary Health Care & Family Medicine
ISSN: (Online) 2071-2936, (Print) 2071-2928
Open Access
Early data from US biotech Moderna has revealed that its Covid-19 vaccine candidate is 94.5 per cent effective, raising hopes that a range of immunisations will be available to help end the pandemic.
The interim analysis of the vaccine, currently known as mRNA-1273, comes after 95 trial particip...
COVAXINTM, India's indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV). The indigenous, inactivated vaccine is developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) h...
Information about vaccine administration
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition...
Comirnaty® 10 μg und 30 μg von BioNTech / Pfizer und Spikevax® von Moderna
Stand 21. Dezember 2021
Comirnaty® 10 μg und 30 μg von BioNTech / Pfizer und Spikevax® von Moderna
Seit August 2021 empfiehlt die Ständige Impfkommission (STIKO) allen Kindern und Jugendlichen ab 12 Jahren die Corona-Schutzimpfung mit Comirnaty® von BioNTech/Pfizer. Seit Mitte Dezember können auch Kinder zwischen 5 und 11 Jahren mit dem darauf angepassten Impfstoff von BioNTech/Pfizer geimpft ...
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covid-19 vaccines. This report updates that assessment ...
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi...
(Comirnaty® 10 мкг або 30 мкг виробництва BioNTech/Pfizer та Spikevax® виробництва Moderna);
Anamnese zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019) (Grundimmunisierung und Auffrischimpfungen)
– mit mRNA-Impfstoffen –
(Comirnaty® 10 μg bzw. ...
– (Comirnaty® 10 мкг або 30 мкг виробництва BioNTech/Pfizer та
AUFKLÄRUNGSMERKBLATT
Zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019) (Grundimmunisierung und Auffrischimpfungen)
– mit mRNA-Impfstoffen –
(Comirnaty® 10 μg bzw. 30 μg von BioNTech/Pfizer...
ІНФОРМАЦІЙНИЙ ЛИСТ Для вакцинації проти COVID-19 (коронавірусне захворювання 2019 р.) (Первинна вакцинація)
recommended
– з вакциною на білковій основі
(Nuvaxovid® виробництва Novavax)
Станом на: 15 лютого 2022 р. (даний інформаційний лист постійно оновлюється)
AUFKLÄRUNGSMERKBLATT
Zur Schutzimpfung gegen COVID-19 (Cor...
En Paraguay, la vacunación contra COVID-19 inició el 22 de febrero de 2021. Se han autorizado un total de siete vacunas: Bharat-Covaxin, Moderna, Pfizer-BioNTech, AstraZeneca, Sinopharm, Sputnik V- Gamaleya y CoronaVac-Sinovac. Los grupos prioritarios de vacunación están definidos según el Plan...
La dosis de refuerzo está indicada una vez transcurridos los 4 meses (120 días) de la última dosis del esquema inicial y será con vacuna de plataforma ARNm: Pfizer-BioNTech pediátrica a partir de los 5 años o Moderna para uso pediátrico a partir de los 6 años.
La evidencia disponible a nivel internacional sobre el uso de un segundo refuerzo muestra una mayor duración de la respuesta inmune y una disminución de la internación y la mortalidad por COVID 19 en la población de adultos mayores y huéspedes inmunocomprometidos. Por otra parte, el personal de...
With the growing prevalence of type 2 diabetes, particularly in emerging countries, its management in the context of available resources should be considered. International guidelines, while comprehensive and scientifically valid, may not be appropriate for regions such as Asia, Latin America or Afr...
